IRIS UniCatt

D'Amico, Adele
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.335
EU - Europa 3.197
AS - Asia 2.639
SA - Sud America 509
AF - Africa 72
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 4
Totale 9.766
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.217
SG - Singapore 1.279
DE - Germania 1.111
CN - Cina 580
BR - Brasile 401
NL - Olanda 379
SE - Svezia 369
IT - Italia 343
FR - Francia 245
VN - Vietnam 203
IE - Irlanda 180
GB - Regno Unito 148
IN - India 117
UA - Ucraina 110
JP - Giappone 86
ID - Indonesia 82
FI - Finlandia 71
RU - Federazione Russa 59
CA - Canada 56
HK - Hong Kong 53
AR - Argentina 49
PL - Polonia 45
BD - Bangladesh 39
TR - Turchia 34
MX - Messico 32
IQ - Iraq 28
ES - Italia 27
KR - Corea 23
ZA - Sudafrica 21
BE - Belgio 19
AT - Austria 17
EC - Ecuador 17
PK - Pakistan 17
IR - Iran 15
CH - Svizzera 13
CO - Colombia 13
MA - Marocco 13
CZ - Repubblica Ceca 12
VE - Venezuela 11
PA - Panama 10
UZ - Uzbekistan 10
LT - Lituania 9
EG - Egitto 8
IL - Israele 8
CI - Costa d'Avorio 7
SA - Arabia Saudita 7
AU - Australia 6
KE - Kenya 6
NP - Nepal 6
PE - Perù 6
PH - Filippine 6
TN - Tunisia 6
CL - Cile 5
CR - Costa Rica 5
MY - Malesia 5
PY - Paraguay 5
RO - Romania 5
AL - Albania 4
AM - Armenia 4
DK - Danimarca 4
DZ - Algeria 4
JM - Giamaica 4
KG - Kirghizistan 4
KZ - Kazakistan 4
OM - Oman 4
SK - Slovacchia (Repubblica Slovacca) 4
TT - Trinidad e Tobago 4
AE - Emirati Arabi Uniti 3
HU - Ungheria 3
LB - Libano 3
LV - Lettonia 3
ME - Montenegro 3
NG - Nigeria 3
NZ - Nuova Zelanda 3
TH - Thailandia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AZ - Azerbaigian 2
BG - Bulgaria 2
BN - Brunei Darussalam 2
GE - Georgia 2
GR - Grecia 2
HR - Croazia 2
LK - Sri Lanka 2
LY - Libia 2
NI - Nicaragua 2
PT - Portogallo 2
TW - Taiwan 2
XK - ???statistics.table.value.countryCode.XK??? 2
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BY - Bielorussia 1
DM - Dominica 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GT - Guatemala 1
HN - Honduras 1
JO - Giordania 1
KH - Cambogia 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
Totale 9.756
Salva come PNG Salva come JPEG
Città #
Singapore 747
Chandler 392
Ashburn 386
Amsterdam 350
San Jose 347
Dublin 166
New York 165
Frankfurt am Main 144
Beijing 112
Los Angeles 91
Tokyo 78
Jakarta 75
Lauterbourg 74
Rome 74
San Mateo 72
Hefei 70
Ho Chi Minh City 62
Milan 62
Jacksonville 61
Hanoi 58
Houston 57
Boston 55
Hong Kong 50
Munich 50
Wilmington 50
Dallas 49
Moscow 43
Nanjing 43
São Paulo 41
Chicago 40
Nürnberg 40
Marseille 38
Santa Clara 33
Helsinki 32
Bremen 30
Princeton 30
Warsaw 29
Woodbridge 29
Ann Arbor 28
Buffalo 28
Dearborn 26
The Dalles 24
Lawrence 23
London 23
Orem 23
Seoul 22
Chennai 21
Brooklyn 20
Denver 20
Nuremberg 19
Paris 19
Seattle 19
Fairfield 18
Kent 17
Johannesburg 16
Lancaster 16
Rio de Janeiro 16
Boardman 15
Changsha 15
Council Bluffs 15
Hebei 15
Izmir 15
Montreal 15
Nanchang 15
Poplar 15
Redwood City 15
San Francisco 15
Toronto 15
Atlanta 14
Brussels 13
Cattolica 13
Inverigo 13
Buenos Aires 12
Da Nang 12
Guangzhou 12
Stockholm 12
Baghdad 11
Mexico City 11
Tianjin 11
Washington 11
Augusta 10
Düsseldorf 10
Norwalk 10
Shanghai 10
Turku 10
Charlotte 9
Detroit 9
Leawood 9
Manchester 9
Phoenix 9
Pune 9
Zhengzhou 9
Belo Horizonte 8
Cambridge 8
Columbus 8
Hangzhou 8
Kish 8
Palermo 8
Shenyang 8
Tashkent 8
Totale 5.210
Salva come PNG Salva come JPEG
Nome #
Safety and efficacy of once-daily risdiplam in type 2 and non-ambulant type 3 spinal muscular atrophy (SUNFISH part 2): a phase 3, double-blind, randomised, placebo-controlled trial 643
Revised upper limb module in type II and III spinal muscular atrophy: 24-month changes 499
Reliability of the Performance of Upper Limb assessment in Duchenne muscular dystrophy 309
Spinal muscular atrophy 246
SMN transcript levels in leukocytes of SMA patients determined by absolute real-time PCR. 179
Salbutamol increases survival motor neuron (SMN) transcript levels in leucocytes of spinal muscular atrophy (SMA) patients: relevance for clinical trial design. 178
Broad phenotypic spectrum and genotype-phenotype correlations in GMPPB-related dystroglycanopathies: an Italian cross-sectional study. 175
Prevalence of Spinal Muscular Atrophy in the Era of Disease-Modifying Therapies: An Italian Nationwide Survey 171
Functional changes in Duchenne muscular dystrophy: a 12-month longitudinal cohort study 165
Type I SMA “new natural history”: long-term data in nusinersen-treated patients 165
SMA-miRs (MiR-181a- 5p, -324-5p, and -451a) are overexpressed in spinal muscular atrophy skeletal muscle and serum samples 160
SMA-miRs (MiR-181a- 5p, -324-5p, and -451a) are overexpressed in spinal muscular atrophy skeletal muscle and serum samples 159
Cardiac Function in Types II and III Spinal Muscular Atrophy: Should We Change Standars of Care? 155
Different trajectories in upper limb and gross motor function in spinal muscular atrophy 153
Expanded access program with Nusinersen in SMA type I in Italy: Strengths and pitfalls of a successful experience 152
Importance of SPP1 genotype as a covariate in clinical trials in Duchenne muscular dystrophy 149
Type I Spinal Muscular Atrophy patients treated with nusinersen: 4 year follow-up of motor, respiratory and bulbar function 142
Clinical-genetic features and peculiar muscle histopathology in infantile DNM1L-related mitochondrial epileptic encephalopathy 142
Sometimes they come back: New and old spinal muscular atrophy adults in the era of nusinersen 142
24 month longitudinal data in ambulant boys with duchenne muscular dystrophy 137
Expanding the clinical-pathological and genetic spectrum of RYR1-related congenital myopathies with cores and minicores: an Italian population study 137
Age, corticosteroid treatment and site of mutations affect motor functional changes in young boys with Duchenne Muscular Dystrophy 134
Genetic characterization in symptomatic female DMD carriers: lack of relationship between X-inactivation, transcriptional DMD allele balancing and phenotype 133
Timed Rise from Floor as a Predictor of Disease Progression in Duchenne Muscular Dystrophy: An Observational Study 133
Revised north star ambulatory assessment for young boys with Duchenne muscular dystrophy 130
Nusinersen efficacy data for 24-month in type 2 and 3 spinal muscular atrophy 130
Prevalence of Duchenne muscular dystrophy in Italy: a nationwide survey 127
Longitudinal Analysis of PUL 2.0 Domains in Ambulant and Non-Ambulant Duchenne Muscular Dystrophy Patients: How do they Change in Relation to Functional Ability? 126
Outcome of fetuses with congenital cytomegalovirus infection: a systematic review and meta-analysis 125
Respiratory Trajectories in Type 2 and 3 Spinal Muscular Atrophy in the iSMAC Cohort Study 125
2-Year Change in Revised Hammersmith Scale Scores in a Large Cohort of Untreated Paediatric Type 2 and 3 SMA Participants 124
Role of prenatal magnetic resonance imaging in fetuses with isolated anomalies of corpus callosum: multinational study 124
Prevalence of Spinal Muscular Atrophy in the Era of Disease-Modifying Therapies: An Italian Nationwide Survey 124
The empowerment of translational research: lessons from laminopathies 122
Genetic modifiers of upper limb function in Duchenne muscular dystrophy 120
Body mass index in type 2 spinal muscular atrophy: a longitudinal study 120
Copy Number Variants Account for a Tiny Fraction of Undiagnosed Myopathic Patients. 119
Patterns of disease progression in type 2 and 3 SMA: Implications for clinical trials 117
An Italian family with autosomal recessive inclusion-body myopathy and mutations in the GNE gene 115
Health-related quality of life and functional changes in DMD: A 12-month longitudinal cohort study 115
Fetal acetylcholine receptor inactivation syndrome and maternal myasthenia gravis: a case report 114
Clinical Variability in Spinal Muscular Atrophy Type III. 113
Healthy design and urban planning strategies, actions, and policy to achieve salutogenic cities 112
Histological effects of givinostat in boys with Duchenne muscular dystrophy 110
Categorizing natural history trajectories of ambulatory function measured by the 6-minute walk distance in patients with Duchenne muscular dystrophy 109
Longitudinal natural history in young boys with Duchenne muscular dystrophy 109
An observational study of functional abilities in infants, children, and adults with type 1 SMA 107
Longitudinal Analysis of PUL 2.0 Domains in Ambulant and Non-Ambulant Duchenne Muscular Dystrophy Patients: How do they Change in Relation to Functional Ability? 106
“Art, Colors, and Emotions” Treatment (ACE-t): A Pilot Study on the Efficacy of an Art-Based Intervention for People With Alzheimer’s Disease 105
Revised upper limb module in type II and III spinal muscular atrophy: 24-month changes 105
MRI in sarcoglycanopathies: a large international cohort study 103
Effect of mexiletine on transitory depression of compound motor action potential in recessive myotonia congenita 102
Development of an academic disease registry for spinal muscular atrophy 102
Registries versus tertiary care centers: How do we measure standards of care in Duchenne muscular dystrophy? 95
New Mutations in NEB Gene Discovered by Targeted Next-Generation Sequencing in Nemaline Myopathy Italian Patients 94
Gain and loss of abilities in type II SMA: A 12-month natural history study 93
The genetic basis of undiagnosed muscular dystrophies and myopathies 92
MRI in sarcoglycanopathies: A large international cohort study 91
Long term follow-up of scoliosis progression in type II SMA patients 90
Mosaic caveolin-3 expression in acquired rippling muscle disease without evidence of myasthenia gravis or acetylcholine receptor autoantibodies 90
Prevalence of Spinal Muscular Atrophy in the Era of Disease-Modifying Therapies: An Italian Nationwide Survey 86
Gene expression profiling in the early phases of DMD: a constant molecular signature characterizes DMD muscle from early postnatal life throughout disease progression. 86
Early Neurodevelopmental Findings Predict School Age Cognitive Abilities in Duchenne Muscular Dystrophy: A Longitudinal Study 83
Sometimes they come back: New and old spinal muscular atrophy adults in the era of nusinersen 82
Novel Splicing Mutation in MTM1 Leading to Two Abnormal Transcripts Causes Severe Myotubular Myopathy 81
null 81
Pathogenic role of mtDNA duplications in mitochondrial diseases associated with mtDNA deletions. 80
Italian recommendations for diagnosis and management of congenital myasthenic syndromes 74
A Recurrent Pathogenic Variant of INPP5K Underlies Autosomal Recessive Congenital Muscular Dystrophy With Cataracts and Intellectual Disability: Evidence for a Founder Effect in Southern Italy 66
Muscle imaging in patients with tubular aggregate myopathy caused by mutations in STIM1 66
null 64
Mitochondrial Neurogastrointestinal Encephalomyopathy Presenting as Anorexia Nervosa 62
Developmental lag of visuospatial attention in Duchenne muscular dystrophy 56
Epithelial IL-6 trans-signaling defines a new asthma phenotype with increased airway inflammation 55
Insulin-like growth factor I in inclusion-body myositis and human muscle cultures 48
1st Italian SMA Family Association Consensus Meeting: Management and recommendations for respiratory involvement in spinal muscular atrophy (SMA) types I-III, Rome, Italy, 30-31 January 2015 29
1st Italian SMA Family Association Consensus Meeting: Management and recommendations for respiratory involvement in spinal muscular atrophy (SMA) types I-III, Rome, Italy, 30-31 January 2015 28
Totale 9.890
Salva come PNG Salva come JPEG
Categoria #
all - tutte 39.573
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.573
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202165 0 0 0 0 0 0 0 0 0 0 63 2
2021/2022526 32 17 9 46 27 26 9 77 37 39 109 98
2022/20231.218 124 152 79 197 84 146 80 97 133 36 62 28
2023/2024820 39 191 43 58 39 159 51 40 22 24 67 87
2024/20251.468 36 47 111 60 139 58 77 77 187 114 299 263
2025/20264.547 526 125 250 533 795 971 677 174 223 238 35 0
Totale 9.890